PCSK9 and mood disorder: In this study, we used genetically predicted protein levels of PCSK9 to proxy the pharmacological effect of PCSK9i, and MR analyses to explore the possibility that protein-targeting PCSK9i might increase the risk of mood disorder traits in the long-term.